Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Journal of Immunology Research|October 27, 2016
Allogeneic Antigen Composition for Preparing Universal Cancer VaccinesPetr G Lokhov, Elena E BalashovaRecent Patents on Biotechnology|December 2, 2016
SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer VaccinesPetr G Lokhov, Elena E BalashovaHuman Vaccines & Immunotherapeutics|February 26, 2015
Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)Petr G Lokhov, Elena E BalashovaJournal of Cancer|December 15, 2010
Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigensPetr G Lokhov, Elena E BalashovaCancers|March 6, 2021
Antigenic Essence: Upgrade of Cellular Cancer VaccinesPetr G Lokhov, Elena E BalashovaHuman Vaccines & Immunotherapeutics|February 28, 2013
Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitroPetr G Lokhov, Elena E BalashovaHuman Vaccines & Immunotherapeutics|April 11, 2013
Universal cancer vaccine: an update on the design of cancer vaccines generated from endothelial cellsPetr G Lokhov, Elena E BalashovaInternational Journal of Molecular Sciences|April 23, 2022
Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen CompositionsPetr G Lokhov, Steven Lichtenberg, Elena E BalashovaMolecular & Cellular Proteomics : MCP|November 15, 2011
Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrenceElena E Balashova, Maxim I Dashtiev, Petr G LokhovJournal of Personalized Medicine|September 8, 2018
A Metabolomics Approach to Pharmacotherapy PersonalizationElena E Balashova, Dmitry L Maslov, Petr G LokhovPageof 5